The Board of Gilead Sciences, Inc. declared a quarterly dividend of $0.77 per share of common stock for the second quarter of 2024. The dividend is payable on June 27, 2024, to stockholders of record at the close of business on June 14, 2024. Future dividends will be subject to Board approval.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.54 USD | +1.17% | -0.61% | -19.10% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.10% | 80.78B | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences, Inc. Declares a Dividend for the Second Quarter of 2024, Payable on June 27, 2024